Современное лечение поверхностного рака мочевого пузыря

Abstract

Summary Superficial bladder cancer (stage Ta-T1) is associated with a high recurrence and progression rate with implications for patient's survival and quality of live. A better understanding of the disease natural history may improve the outcome in superficial bladder cancer patients. The information was gathered from MEDLINE, current urology Journals, abstracts from recent urological meetings and personal experience. Initial treatment consists of complete transurethral resection, tumor bed cold cup biopsy with subsequent vaporization, and adjuvant treatment with intravesical instillation of bacillus Calmefte-Guerin (BCG) or interferon a-2b. Fluorescent cystoscopy, second look TUR allow to decrease risk of progression and recurrence. Early diagnosis and accurate pathological assessment are essential for determining the most adequate treatment strategy.